儿童社区获得性肺炎的生物标志物与疾病严重程度
该前瞻性队列研究纳入477例3月龄至18岁社区获得性肺炎(CAP)患儿,评估白细胞计数、中性粒细胞绝对计数、C反应蛋白(CRP)和降钙素原与严重结局的关联。结果显示这些生物标志物在区分非重症与重症方面总体价值有限,但CRP和降钙素原对预测最严重结局(如需要胸引流的脓胸、需要血管活性药物输注的脓毒症)可能有一定作用。
要点
- WBC、ANC、CRP和降钙素原在不同严重程度类别间中位数无统计学差异。
- 无一生物标志物能充分区分重症与非重症(AUC 0.53-0.64)。
- CRP和降钙素原对预测最严重结局(脓胸需引流、脓毒症需血管活性药)有较好区分度。
核心结论
- WBC计数、ANC、CRP和降钙素原通常不能区分儿童CAP的非重症与重症疾病,但CRP和降钙素原可能有助于预测最严重的结局。
研究设计与样本
- 前瞻性队列研究,纳入477例3月龄至18岁在急诊科诊断为CAP的儿童。
- 主要结局为疾病严重程度:轻度(出院)、轻中度(住院但非中重度或重度)、中重度(如住院接受静脉输液、补充氧气、复杂性肺炎)、重度(如重症监护、血管活性药物输注、胸腔引流、严重脓毒症)。
- 在疑似CAP队列和影像学CAP亚组中分析结局。
主要发现
- 在477例患儿中,不同严重程度类别间WBC计数、ANC、CRP和降钙素原的中位数无统计学差异。
- 无一生物标志物对重症与非重症有足够区分能力(疑似CAP的AUC为0.53-0.6,影像学CAP的AUC为0.59-0.64)。
- 在调整年龄、抗生素使用、发热持续时间和病毒病原体检测的分析中,CRP与中重度疾病相关(OR 1.12;95%CI 1.0-1.25)。
- CRP和降钙素原对需要胸腔引流的脓胸有良好区分度(AUC 0.83),对需要血管活性药物输注的脓毒症(CRP AUC 0.74;降钙素原AUC 0.78),但这些结局的患病率较低。
临床怎么用
- 临床不应常规依赖WBC、ANC、CRP或降钙素原来区分儿童CAP的重症与非重症。
- CRP和降钙素原可能有助于识别最严重结局(如脓胸需引流、脓毒症需血管活性药),但需结合临床评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Host biomarkers predict disease severity in adults with community-acquired pneumonia (CAP). We evaluated the association of the white blood cell (WBC) count, absolute neutrophil count (ANC), C-reactive protein (CRP), and procalcitonin with the development of severe outcomes in children with CAP. METHODS: We performed a prospective cohort study of children 3 months to 18 years of age with CAP in the emergency department. The primary outcome was disease severity: mild (discharged from the hospital), mild-moderate (hospitalized but not moderate-severe or severe), moderate-severe (eg, hospitalized with receipt of intravenous fluids, supplemental oxygen, complicated pneumonia), and severe (eg, intensive care, vasoactive infusions, chest drainage, severe sepsis). Outcomes were examined within the cohort with suspected CAP and in a subset with radiographic CAP. RESULTS: Of 477 children, there were no statistical differences in the median WBC count, ANC, CRP, or procalcitonin across severity categories. No biomarker had adequate discriminatory ability between severe and nonsevere disease (area under the curve [AUC]: 0.53-0.6 for suspected CAP and 0.59-0.64 for radiographic CAP). In analyses adjusted for age, antibiotic use, fever duration, and viral pathogen detection, CRP was associated with moderate-severe disease (odds ratio 1.12; 95% confidence interval, 1.0-1.25). CRP and procalcitonin revealed good discrimination of children with empyema requiring chest drainage (AUC: 0.83) and sepsis with vasoactive infusions (CRP AUC: 0.74; procalcitonin AUC: 0.78), although prevalence of these outcomes was low. CONCLUSIONS: WBC count, ANC, CRP, and procalcitonin are generally not useful to discriminate nonsevere from severe disease in children with CAP, although CRP and procalcitonin may have some utility in predicting the most severe outcomes.
引用
- Florin TA, Ambroggio L, Brokamp C, et al. Biomarkers and Disease Severity in Children With Community-Acquired Pneumonia. Pediatrics. 2020. PMID: 32404432. doi:10.1542/peds.2019-3728
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。